A postmarketing, open-label study to evaluate the tolerability and effectiveness of replacing standard-formulation doxazosin with doxazosin in the gastrointestinal therapeutic system formulation in adult patients with hypertension

  1. Anegón, M.
  2. Esteban, J.
  3. Jiménez-García, R.
  4. Sanz De Burgoa, V.
  5. Martínez, J.
  6. Gil De Miguel, A.
Aldizkaria:
Clinical Therapeutics

ISSN: 1879-114X,  0149-2918

Argitalpen urtea: 2002

Alea: 24

Zenbakia: 5

Orrialdeak: 786-797

Mota: Artikulua

DOI: 10.1016/S0149-2918(02)85152-9 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus